PMID: 6412385Aug 1, 1983Paper

Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies

Thorax
N M BraunD F Rochester

Abstract

We studied 53 patients with proximal myopathy to determine at what level of muscle weakness hypercapnic respiratory failure is likely, and which tests of pulmonary function or respiratory muscle strength would best suggest this development. Respiratory muscle strength was determined from maximal static efforts and in half the patients, both inspiratory and expiratory muscle strengths were less than 50% of normal. In the 37 patients without lung disease respiratory muscle weakness was accompanied by significant decreases in vital capacity, total lung capacity, and maximum voluntary ventilation; by significant increases in residual volume and arterial carbon dioxide tension (PaCO2); and greater likelihood of dependence on ventilators, atelectasis, and pneumonia. Hypercapnia was particularly likely when respiratory muscle strength was less than 30% of normal in uncomplicated myopathy, and when vital capacity was less than 55% of the predicted value in any patient.

References

Sep 1, 1977·The American Journal of Medicine·D J RileyN H Edelman
Jan 1, 1978·Muscle & Nerve·S DiMauroC Payne
Jan 1, 1979·Respiration; International Review of Thoracic Diseases·M H LavietesL B Reichman
Dec 1, 1977·Neurology·J E CarrollJ V Weil
Jun 1, 1980·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·T J Gal, S K Goldberg
Jan 1, 1981·Archives of Neurology·R C GriggsR T Moxley
Apr 14, 1955·The New England Journal of Medicine·B G FERRISC A BEALS
Nov 26, 1959·The New England Journal of Medicine·K H KILBURNA HEYMAN
Apr 1, 1952·The American Journal of Medicine·D S LUKAS, F PLUM
Aug 1, 1952·The Journal of Clinical Investigation·J A FELTMANF J LOVELOCK

❮ Previous
Next ❯

Citations

Oct 1, 1986·Italian Journal of Neurological Sciences·A Lissoni, F Molteni
Jan 1, 1989·Lung·P G Wilcox, R L Pardy
Jan 1, 1991·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·P J John, A A Mahashur
Sep 29, 2006·Lung·Alexandra ChroneouGeorge Politis
May 3, 2011·Journal of Neurology·Bart W SmitsBaziel G M van Engelen
Jan 12, 2007·Clinical Rheumatology·Figen GökoğluFigen Ayhan Ardiç
May 22, 2002·European Journal of Internal Medicine·Gaëlle DauriatHervé Mal
Aug 18, 2000·Journal of Internal Medicine·T PietersM Lambert
Jun 6, 2008·Journal of Clinical Neuromuscular Disease·Romy HoqueAndrew L Chesson
Jul 1, 1992·Anaesthesia·C Lanigan
Aug 1, 1990·Alcoholism, Clinical and Experimental Research·M B ReidM J Miller
Apr 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·R A Hughes, D Bihari
Jul 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·J M Shneerson
Jan 14, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·M I PolkeyP N Leigh
Oct 1, 1992·Postgraduate Medical Journal·J WhiteG J Gibson
Jul 31, 1998·Postgraduate Medical Journal·N Syabbalo
Apr 1, 1990·Thorax·P T ByeC E Sullivan
Jan 1, 1991·Thorax·J Goldstone, J Moxham
Jul 1, 1997·American Journal of Respiratory and Critical Care Medicine·P BéginA Grassino
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·J M PoponickA F DiMarco
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·M F PhillipsP M Calverley
Feb 17, 2001·American Journal of Respiratory and Critical Care Medicine·S Mehta, N S Hill
Jun 1, 1988·The American Review of Respiratory Disease·S K Pingleton
Aug 21, 2002·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society/European Respiratory Society
Nov 2, 2002·American Journal of Respiratory and Critical Care Medicine·Franco LaghiMartin J Tobin
Apr 18, 2013·American Journal of Respiratory and Critical Care Medicine·Joshua O Benditt, Louis J Boitano
Jun 27, 2003·American Journal of Respiratory and Critical Care Medicine·Franco Laghi, Martin J Tobin
May 1, 1985·The Journal of Clinical Investigation·D F Rochester
Sep 1, 1993·The Journal of Clinical Investigation·P N DekhuijzenM Decramer
Apr 23, 2014·Rejuvenation Research·Renato GiuaRaffaele Antonelli Incalzi
Sep 10, 2002·Current Rheumatology Reports·Dana P Ascherman
Jul 14, 2000·Chest·S W Kang, J R Bach
Jan 24, 2006·American Journal of Physical Medicine & Rehabilitation·John R BachPaulo Abreu
Jun 7, 2006·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Kathleen Marya ChaissonRobert L Vender

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.